Navigation Links
InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
Date:7/24/2013

BRISBANE, Calif., July 24, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the second quarter ended June 30, 2013, and recent business highlights.(Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO)

InterMune reported Esbriet® (pirfenidone) revenue in the second quarter of 2013 of $14.4 million, compared with $5.5 million of Esbriet revenue in the same quarter of 2012.  Sequentially, Esbriet revenue in the second quarter of 2013 increased 37 percent from $10.5 million in the first quarter of 2013.Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "We continue to successfully execute on our EU and Canadian growth strategy and are pleased to report the seventh consecutive quarter of revenue growth of Esbriet since its first launch in Germany in September 2011.  Having recently secured attractive pricing and reimbursement in Italy, England and Ireland, Esbriet is now priced and reimbursed in 13 of our original 15 top-priority European countries, a solid achievement when considering the challenging economic conditions in the EU.

"Regarding the U.S. market, we remain on track to report top-line results from the confirmatory Phase 3 ASCEND study of Esbriet in Q2 2014," Mr. Welch added.

Recent Business and Clinical Development Highlights

  • On April 22, 2013, the health technology appraisal body in England and Wales, NICE, recommended Esbriet for treating idiopathic pulmonary fibrosis (IPF) patients whose predicted forced vital capacity (FVC) is between 50 percent and 80 percent at the initiation of therapy. The Final Guidance recommends the prescription of Esbriet as long as InterMune makes the Patient Access Scheme (PAS) available. The PAS is a confidential pricing and access agree
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
    2. InterMune Announces Presentations of New Research in IPF at ERS
    3. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
    4. InterMune to Divest Actimmune® (Interferon Gamma-1b)
    5. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
    6. Lilly Reports Second-Quarter 2013 Results
    7. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
    8. Danaher Reports Record Second Quarter 2013 Results
    9. Pharmsynthez Reports Full Year 2012 Results in line US GAAP Financial Reporting
    10. Johnson & Johnson Reports 2013 Second-Quarter Results:
    11. South Asia Medical Device Market Reports
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... Aug. 21, 2014  Armada Health Care (Armada), ... (GPO), is pleased to announce an agreement with ... host of innovative specialty pharmacy patient program offerings. ... therapy management services to specialty patients via Armada,s ... Aurora will use the OTM platform as ...
    (Date:8/21/2014)... 2014 Professional Compounding Centers of America ... awarding the three best scientific presentations at the ... . The Formulating Better Medicines for Children ... Athens, Greece , includes dozens of ... from which three winners will be selected by ...
    (Date:8/21/2014)...  SI-BONE, Inc. ( San Jose, California ... of the iFuse Implant System, ® a minimally ... sacroiliac (SI) joint, announced that Priority Health ( ... Fusion Medical Policy No. 91590-R4 providing positive coverage for ... that the fusion procedure, which employs the iFuse Implant ...
    Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
    ... Calif. , Feb. 18 AutoGenomics, a ... that the organization has been awarded the ISO 13485 ... throughout the organization. TUV SUD America Inc. was the ... looks to expand its increasing role in the international ...
    ... CAUSE NO. 2010-10259, , BRAD KOVNAT, ... , ... , v. ... , THE PALLADIUM FOR SURGERY- ...
    Cached Medicine Technology:AutoGenomics Receives ISO Certification 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9
    (Date:8/21/2014)... 21, 2014 The ... Vascular Devices Market by Angioplasty Balloon ... (IVUS, OCT), IVC Filter (Retrievable), Endovascular ... analyzes and studies the major market ... U.S. and Canada. , Browse 108 ...
    (Date:8/21/2014)... Bedros Keuilian’s Annual Fitness Business Summit is considered the ... people already earning seven-figure incomes. But his annual Fit ... to the owners of Keuilian’s own international fitness boot camp ... Boot Camp World Conference will also be attended by 50 ... or are struggling with their own boot camp businesses. ...
    (Date:8/21/2014)... August 21, 2014 mynt welcomes industry ... promoters to join its growing company. Since its pre-launch ... in product sales and continues to gain momentum leading ... , Rob and Tiffanie came into network marketing by ... a number of network marketing companies. Tiffanie needed help ...
    (Date:8/21/2014)... Truly hungry, or comforting yourself with food? ... driving, or at the computer can lead to significant ... aware of what they eat and why during the ... , Registered dietician and community educator Bridget Lackey will ... to 2 p.m. Sept. 5 at Humility House, 755 ...
    (Date:8/21/2014)... One of the emerging trends in the market ... This increases the availability and accessibility of these products to ... Ostomy Care Accessories market to grow at a ... the report, the Global Ostomy Care Accessories market is driven ... the major drivers. The number of procedures is increasing owing ...
    Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:HMHP Workshop to Focus on ‘Mindful’ Eating 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4
    ... Center basic scientists Roger Brent, Ph.D., a systems biologist, ... have been elected fellows of the American Association for ... fellow is an honor bestowed upon AAAS members by ... Center,s Basic Sciences Division, is being honored "for outstanding ...
    ... Cambridge, MASS. -- Researchers at MIT and Brigham and Women,s ... cisplatin much more effectively and safely in a form that ... cells and is activated once it reaches its target. ... shrink tumors in mice, using only one-third the amount of ...
    ... By Randy Dotinga HealthDay Reporter , TUESDAY, Jan. ... change your kid,s attitude: The most optimistic adolescents may be ... Researchers also have found a slight link between optimism ... are caveats. The new research, on kids in Australia, doesn,t ...
    ... Reporter , TUESDAY, Jan. 11 (HealthDay News) -- After ... are "special," today,s young people crave these boosts to ... new research suggests. The self-esteem movement of recent ... success and praise in a world that won,t necessarily ...
    ... Jan. 11, 2011 An international team of researchers ... human papillomavirus that one day may aid in the ... Led by researcher Per Jemth of Uppsala University in ... Journal of Biological Chemistry how an offensive ...
    ... brachytherapy has advantages compared to other therapy options in men ... in this respect. This is the result of a report ... Care (IQWiG) on 11 January 2011. In this report IQWiG ... completed in 2007. However, it was shown that no relevant ...
    Cached Medicine News:Health News:Roger Brent and Robert Eisenman named AAAS fellows 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 3Health News:Optimism Could Help Kids Keep Depression at Bay 2Health News:For College Students, Praise May Trump Sex and Money 2Health News:For College Students, Praise May Trump Sex and Money 3Health News:Study details how protein made by HPV teams up on and thwarts protective human protein 2Health News:Study details how protein made by HPV teams up on and thwarts protective human protein 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4
    Flagship Transcranial Doppler system with multiple channel options, multi-depth options....
    Swiss Watchmaker Forceps, 4" extra-long precision ground points....
    ... fine tips and are intended for the most ... The curved ones are ideal for tweezing out ... student versions are for beginners. These Dumont/Swiss watchmaker ... The Swiss forceps are made from the highest ...
    Verte-Span is the latest advancement in vertebral body replacement technology. This device allows surgeons to reconstruct and stabilize certain types of anterior column defects in the spine....
    Medicine Products: